A multidisciplinary research team co-led by a prominent physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver…
Read More

A multidisciplinary research team co-led by a prominent physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver…
Read More
The meteoric rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally altered the landscape of metabolic medicine in the United…
Read More
The rapid rise of glucagon-receptor agonists (GLP-1) has transformed the landscape of metabolic health, offering unprecedented results for individuals struggling…
Read More
The rapid rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally transformed the landscape of metabolic medicine and obesity treatment…
Read More
A groundbreaking study co-led by a physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver Heart Center…
Read More
The rapid ascent of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), has transformed…
Read More
In an era defined by a rapidly aging global population, the medical community is facing an unprecedented rise in age-related…
Read More
In a landmark study that challenges long-held medical dogmas regarding the permanent nature of cardiac damage, a multidisciplinary team of…
Read More
The rapid rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally altered the landscape of metabolic health and weight management…
Read More
In a breakthrough that redefines the biological understanding of the relationship between the muscular and nervous systems, engineers at the…
Read More